Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer for B2B Healthcare
TL/DR –
Walgreens has recruited Jason Stenta as its new SVP and Chief Commercial Officer to develop its B2B healthcare services division. Stenta previously held senior roles at Optum and CVS Health. His new role will involve building partnerships with payers, health system providers and life sciences firms, as well as supporting the rollout of B2B healthcare services based on Walgreens’ core assets.
Walgreens Welcomes New SVP and Chief Commercial Officer
Walgreens has appointed Jason Stenta as the new SVP and Chief Commercial Officer to boost its B2B healthcare services division. Prior to joining Walgreens, Stenta held multiple leadership roles including SVP, Payer Sales for Optum, a UnitedHealth Group company, and at CVS Health for 10 years.
According to Mary Langowski, EVP and President, U.S. Healthcare, at Walgreens Boots Alliance (WBA), Jason’s in-depth understanding of market dynamics, regulatory requirements, and customer needs, coupled with his experience with complex healthcare organizations, will prove instrumental in strengthening Walgreens’ healthcare solutions and relationships.
Strengthening Walgreens’ Retail Pharmacy Services
Walgreens, a multi-faceted healthcare, pharmacy and retail business, serves millions of customers daily. In his new role, Stenta will aid the commercialization of B2B healthcare services and improve collaborations with payers, health system providers and life sciences companies. He aims to leverage Walgreens’ core strengths in retail pharmacy to provide partners with much-needed healthcare solutions.
Stenta expressed his enthusiasm about his new role and the expansion plans at Walgreens, emphasizing the key role of the company’s strengths and services in retail pharmacy.
This appointment is part of Walgreens’ ongoing turnaround efforts. In recent months, the retailer has hired executives including Tracey Koller, former Party City veteran, as SVP and Chief Merchandising Officer, and Sharmila Sudhakar as Group VP and Head of Walgreens Digital Commerce. The turnaround plan, announced in June 2024, includes the closure of several underperforming stores and a focus on enhancing the core retail pharmacy business, described by CEO Tim Wentworth as “central to the future of healthcare”.
—
Read More Health & Wellness News ; US News